AlveoGene’s Inhaled Therapy AVG-002 Gets FDA Orphan Designation
03 Dec 2024 //
GLOBENEWSWIRE
AlveoGene Gets FDA Rare Pediatric Disease Designation for AVG-002
15 Nov 2024 //
GLOBENEWSWIRE
AlveoGene Launches to Develop Unique Inhaled Gene Therapies
14 Sep 2023 //
GLOBENEWSWIRE